Tokyo, Feb. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060552) titled 'Physicians' practical status about treat to target in ulcerative colitis' on Feb. 2.
Study Type:
Observational
Primary Sponsor:
Institute - EA Pharma Co., Ltd.
Condition:
Condition - Ulcerative colitis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The objective of this study is to elucidate, through an internet based survey, the level of awareness and implementation of the treat to target (T2T) strategy in the clinical management of ulcerative colitis (UC) in Japan, and to characterize the current patterns of biomarker utilization as well as the factors underlyin...